Cetilistat Uses, Dosage, Side Effects and more
Cetilistat is a novel inhibitor of pancreatic lipase being developed by Alizyme for the treatment of obesity and associated co-morbidities, including type 2 diabetes.
| Trade Name | Cetilistat |
| Generic | Cetilistat |
| Cetilistat Other Names | Cetilistat |
| Type | |
| Formula | C25H39NO3 |
| Weight | Average: 401.5821 Monoisotopic: 401.292994119 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in obesity.
How Cetilistat works
Cetilistat is a gastrointestinal lipase inhibitor that blocks fat digestion and absorption, leading to reduced energy intake, and thus weight loss. It is distinct from most other anti-obesity agents as it does not act on the brain to reduce appetite, but acts peripherally. The compound remains in the gastrointestinal tract with no significant absorption into the body.
